Boston, MA 04/04/2014 (wallstreetpr) – Intuitive Surgical, Inc. (NASDAQ:ISRG) is a provider of surgical robotics. The stock is among the most intriguing on the market currently and this is because it recently won the approval of the Food and Drug Administration for its newest surgical system called da Vinci Xi. Shares are currently up and have been able to make up for the loss suffered prior to the FDA approval of the latest system.
The fact that the company has brought a new product on the market which comes as improvement of its previous system and the fair price of the stock leads us to believe that investors have something to gain from this company. Talk about fair valuation of the stock and Intuitive looks ripe for uptake on dip. Shares of the company have skyrocketed to about 20 percent since the positive announcement about FDA clearance of Xi came out. The shares had fallen about 25 percent from February 2013 to the day before the FDA approval was obtained. The stock has been in a mixed rally in the past, with notable decline in recent times.
Now with a new product on the market, shares are likely to fly high again and jumping in on a dip can be very rewarding.
Smart investment opportunity
Securing FDA clearance for its newest systems tells a lot about how the market is going to receive the device. It was feared that regulators might turn a negative view about Xi, especially bearing in mind that Intuitive Surgical, Inc. (NASDAQ:ISRG)’s old system had been soaked in questions about safety and cost-effectiveness. But it seems regulators are convinced that Xi presents the very best solution for invasive surgery procedures. This should lead to more hospitals acquiring the system.
Additional features
The newest surgery system from Intuitive Surgical, Inc. (NASDAQ:ISRG) comes with more features, among them ability to allow surgeons gain access to multiple surgical sites without the need for reposition. Other features such as imaging system and power supply have also been improved. And even with these improvements, the device is priced fairly, almost the same price as the old system.
